(Q37116825)

18 August 2017

Transcatheter arterial embolization therapy for a massive polycystic liver in autosomal dominant polycystic kidney disease patients (English)

1 reference

autosomal dominant polycystic kidney disease

18 August 2017

0 references

autosomal dominant polycystic kidney

1 reference

1

Hayne Cho Park

1 reference

18 August 2017

11

Curie Ahn

1 reference

18 August 2017

5

Kook-Hwan Oh

1 reference

18 August 2017

3

Han Ro

1 reference

18 August 2017

12

Young-Hwan Hwang

1 reference

18 August 2017

6

Yonsu Kim

1 reference

18 August 2017

7

Jung Sang Lee

1 reference

18 August 2017

Chi Weon Kim

2

1 reference

18 August 2017

Ju-Young Moon

4

1 reference

18 August 2017

Yong Hu Yin

8

1 reference

18 August 2017

Hwan Jun Jae

9

1 reference

18 August 2017

Jin Wook Chung

10

1 reference

18 August 2017

28 February 2009

1 reference

Journal of Korean Medical Science

18 August 2017

1 reference

18 August 2017

24

1 reference

18 August 2017

1

1 reference

18 August 2017

57-61

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

18 August 2017

start time

1 January 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Results of percutaneous sclerotherapy and surgical treatment in patients with symptomatic simple liver cysts and polycystic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650978

New advances in evaluation and management of patients with polycystic liver disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650978

Laparoscopic palliation of polycystic liver disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650978

Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650978

Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650978

Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650978

Treatment of polycystic liver disease: one size does not fit all.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650978

Intravascular embolization therapy in a patient with an enlarged polycystic liver

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19270814

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

New therapeutic option for autosomal dominant polycystic kidney disease patients with enlarged kidney and liver

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19270814

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3346/JKMS.2009.24.1.57

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19270814

1 reference